GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lisata Therapeutics Inc (FRA:8NE) » Definitions » Sale Of Investment

Lisata Therapeutics (FRA:8NE) Sale Of Investment : €92.10 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Lisata Therapeutics Sale Of Investment?

Lisata Therapeutics's sale of investment for the three months ended in Mar. 2024 was €23.33 Mil. It means Lisata Therapeutics gained €23.33 Mil from selling investments. Lisata Therapeutics's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €92.10 Mil.

Compared with last quarter (€14.13 Mil in Dec. 2023 ), Lisata Therapeutics gained more money from selling investments in Mar. 2024 (€23.33 Mil).


Lisata Therapeutics Sale Of Investment Historical Data

The historical data trend for Lisata Therapeutics's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lisata Therapeutics Sale Of Investment Chart

Lisata Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.93 22.64 110.57 115.36 99.57

Lisata Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.14 27.68 26.96 14.13 23.33

Lisata Therapeutics Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €92.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lisata Therapeutics Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Lisata Therapeutics's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Lisata Therapeutics (FRA:8NE) Business Description

Traded in Other Exchanges
Address
110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.

Lisata Therapeutics (FRA:8NE) Headlines

No Headlines